Balyasny Asset Management’s Dianthus Therapeutics DNTH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,371	Closed	-$401K	–	2030
2024 Q1	$401K	Buy	+13,371	New	+$401K	﹤0.01%	1552
2022 Q4	–	Sell	-761	Closed	-$17K	–	2409
2022 Q3	$17K	Buy	+761	New	+$17K	﹤0.01%	2109